p-Cresyl Sulfate Predicts Ischemic Stroke among Patients on Hemodialysis: A Prospective Cohort Study
Open Access
- 31 January 2022
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2022, 1-8
Abstract
Background and Purpose. Hemodialysis patients face a higher risk of ischemic stroke. p-Cresyl sulfate is a typical protein-bound uremic toxin that contributes to chronic kidney disease and cardiovascular disease progression, as well as mortality in hemodialysis patients. The present study was aimed at elucidating the association between p-cresyl sulfate and the risk of ischemic stroke in hemodialysis patients. Method. Patients on hemodialysis over 6 months were enrolled in this prospective cohort study and were divided into 2 groups based on plasma p-cresyl sulfate level. The primary end point was the first episode of ischemic stroke during follow-up. The association between p-cresyl sulfate and ischemic stroke incidence was analyzed by Kaplan-Meier method and Cox proportional hazard model. Results. 220 patients were enrolled in this study. 44 patients experienced episodes of first ischemic stroke during follow-up for 87.8 (47.6-119.5) months. Kaplan-Meier analysis demonstrated that the incidence of ischemic stroke in the high p-cresyl sulfate group was significantly higher than that in the low p-cresyl sulfate group (Log-Rank ). Cox regression analysis as well proved that p-cresyl sulfate level was significantly associated with the first incidence of ischemic stroke (HR (hazard ratio) 2.332, 95% CI (95% confidence interval) 1.236-4.399, ). After being adjusted for other confounding risk factors, the results persisted significant (model 11: HR 2.061, 95% CI 1.030-4.125, ). Conclusion. Plasma p-cresyl sulfate predicts the first incidence of ischemic stroke in hemodialysis patients.Keywords
Funding Information
- Shanghai Key Laboratory of Kidney and Blood Purification (20DZ2271600, 2017ZZ01015, 2020ZSLC09)
- Shanghai Most Important Clinical Medical Center and Key Discipline Construction Program (20DZ2271600, 2017ZZ01015, 2020ZSLC09)
- Zhongshan Hospital Affiliated to Fudan University (20DZ2271600, 2017ZZ01015, 2020ZSLC09)
This publication has 34 references indexed in Scilit:
- Numerous protein-bound solutes are cleared by the kidney with high efficiencyKidney International, 2013
- Role of the vascular endothelium and plaque in acute ischemic strokeNeurology, 2012
- Indoxyl Sulfate Predicts Cardiovascular Disease and Renal Function Deterioration in Advanced Chronic Kidney DiseaseArchives of Medical Research, 2012
- Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort studyNephrology Dialysis Transplantation, 2011
- Indoxyl Sulfate–Induced Endothelial Dysfunction in Patients with Chronic Kidney Disease via an Induction of Oxidative StressClinical Journal of the American Society of Nephrology, 2011
- Cellular Microparticles as a Marker for Cerebral Vasospasm in Spontaneous Subarachnoid HemorrhageStroke, 2010
- p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney diseaseNephrology Dialysis Transplantation, 2010
- The Uremic Retention Solute p-Cresyl Sulfate and Markers of Endothelial DamageAmerican Journal of Kidney Diseases, 2009
- P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical productionNephrology Dialysis Transplantation, 2006
- Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patientsKidney International, 2006